Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (71-80 of 741) with videos related to

Pageof 75
Sort By:
ACS Chemical Neuroscience|February 9, 2016
TREM2 Function in Alzheimer's Disease and NeurodegenerationJason D Ulrich, David M Holtzman
Vaccine|June 24, 2025
Accelerating development of vaccines for prevention and control of Alzheimer's diseaseWayne C Koff, David M Holtzman
Cell|October 1, 2019
Alzheimer Disease: An Update on Pathobiology and Treatment StrategiesJustin M Long, David M Holtzman
Current Opinion in Neurology|October 9, 2012
Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvementErik S Musiek, David M Holtzman
Nature Medicine|September 4, 2023
Emerging diagnostics and therapeutics for Alzheimer diseaseWade K Self, David M Holtzman
Experimental Neurology|November 29, 2005
Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injuryDavid L Brody, David M Holtzman
Annual Review of Neuroscience|March 21, 2008
Active and passive immunotherapy for neurodegenerative disordersDavid L Brody, David M Holtzman
Neuron|December 11, 2012
Stealth attack: plaque-specific antibody allows for efficient Aβ removal without side effectsJee Hoon Roh, David M Holtzman
Science (New York, N.Y.)|November 26, 2016
Mechanisms linking circadian clocks, sleep, and neurodegenerationErik S Musiek, David M Holtzman
Experimental Neurology|September 6, 2003
Differential metabolism of ApoE isoforms in plasma and CSFSuzanne E Wahrle, David M Holtzman
Pageof 75

Showing results (71-80 of 741) with videos related to

Sort By:
Pageof 75
ACS Chemical Neuroscience|February 9, 2016
TREM2 Function in Alzheimer's Disease and NeurodegenerationJason D Ulrich, David M Holtzman
Vaccine|June 24, 2025
Accelerating development of vaccines for prevention and control of Alzheimer's diseaseWayne C Koff, David M Holtzman
Cell|October 1, 2019
Alzheimer Disease: An Update on Pathobiology and Treatment StrategiesJustin M Long, David M Holtzman
Current Opinion in Neurology|October 9, 2012
Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvementErik S Musiek, David M Holtzman
Nature Medicine|September 4, 2023
Emerging diagnostics and therapeutics for Alzheimer diseaseWade K Self, David M Holtzman
Experimental Neurology|November 29, 2005
Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injuryDavid L Brody, David M Holtzman
Annual Review of Neuroscience|March 21, 2008
Active and passive immunotherapy for neurodegenerative disordersDavid L Brody, David M Holtzman
Neuron|December 11, 2012
Stealth attack: plaque-specific antibody allows for efficient Aβ removal without side effectsJee Hoon Roh, David M Holtzman
Science (New York, N.Y.)|November 26, 2016
Mechanisms linking circadian clocks, sleep, and neurodegenerationErik S Musiek, David M Holtzman
Experimental Neurology|September 6, 2003
Differential metabolism of ApoE isoforms in plasma and CSFSuzanne E Wahrle, David M Holtzman
Pageof 75